Trial Profile
Phase I Study to Evaluate the Safety, Tolerability, PK and Pharmacodynamics of 3 Dosages of Estetrol, the Lowest Dose of 2 mg Estetrol Compared With 2 mg of E2, After Daily Oral Administration for 28 Days in Healthy Postmenopausal Women.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Estetrol (Primary) ; Estradiol (Primary)
- Indications Menopausal syndrome
- Focus Adverse reactions
- 23 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jun 2011 Actual end date (Sep 2007) added as reported by ClinicalTrials.gov.
- 28 Oct 2006 New trial record.